We are delighted to share that our partners in GBM Project, Dr. Tobias Weiss and Miaomiao Sun from Universitätsspital Zürich, will be speaking at the upcoming 28th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) in Vancouver, Canada, on November 17, 2023.
SNO 2023 is the world’s largest neuro-oncology conference, bringing together over 2600 researchers and clinician scientists from 40+ countries. This year’s theme, “Neuro-Oncology at the Intersections: Multidisciplinary Approaches to Improve Patient Outcomes,” promises to be an invaluable forum for advancing neuro-oncology research and treatment.
Dr. Tobias Weiss will be presenting several lectures, including:
> CTIM-22: Phase I study results of the antibody-cytokine fusion protein L19TNF in combination with lomustine for patients with recurrent glioblastoma. Date: November 17, 2023, 8:15 AM – 8:20 AM PT.
> DDDR-24: Single-cell functional tissue profiling identifies promising candidates for drug repurposing against glioblastoma. Date: November 17, 2023, 11:25 AM – 11:35 AM PT.
> EXTH-80: A systemic comparison of CAR T cells, CAR NK cells, and CAR macrophages for glioma treatment. Date: November 17, 2023, 4:55 PM – 5:00 PM PT.
Miaomiao Sun will also be a part of this event, presenting:
> EXTH-75: A macrophage-based drug delivery platform for glioma treatment. Date: November 17, 2023, 4:05 PM – 4:15 PM PT.
Don’t miss this fantastic opportunity to gain insights and collaborate with our outstanding team in the field of neuro-oncology. See you at SNO 2023! 🧠 #SNO2023 #NeuroOncology #ResearchInnovation
